Associated Papers
Nabais Sa-de Vries syndrome in a Chinese infant associated with a novel SPOP mutation: A clinical study and genetic report.
Hu W et al.
Molecular Genetics & Genomic Medicine, 2022
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer.
Bernasocchi T et al.
Nature Communications, 2021
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
Nabais Sá MJ et al.
American Journal of Human Genetics, 2020
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.
Yan Y et al.
Embo Molecular Medicine, 2019
Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.
Saar M et al.
Cancer Letters, 2014
Select a paper to view details